OL
VERA icon

Odyssean LLC’s Vera Therapeutics VERA Stock Holding History

Odyssean LLC’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
60,005
+39,495
+193% +$1.47M 0.42% 101
2026
Q1 		$825K Buy
20,510
+13,014
+174% +$561K 0.3% 135
2025
Q4 		$380K Buy
+7,496
New +$266K 0.27% 181

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Odyssean LLC's VERA Position: Q2 2026 in Review

Odyssean LLC increased its Vera Therapeutics (VERA) stake by 193% in Q2 2026, buying an estimated $1.47M and bringing the position to 60,005 shares worth $2.57M. The position accounts for 0.42% of the portfolio, ranked #101.

Odyssean LLC first reported a position in VERA in Q4 2025 and has held it in 3 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Odyssean LLC held 60,005 shares of Vera Therapeutics worth $2.57M as of Q2 2026.
  • Odyssean LLC bought 39,495 Vera Therapeutics shares in Q2 2026, an estimated $1.47M.
  • Vera Therapeutics made up 0.42% of Odyssean LLC's portfolio in Q2 2026, its #101 holding.
  • Odyssean LLC first reported a position in Vera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.